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Abstract
Background: The PHQ-9 and the GAD-7 assess depression and anxiety respectively. There are standardised,
reliability-tested versions in BSL (British Sign Language) that are used with Deaf users of the IAPT service. The
aim of this study is to determine their appropriate clinical cut-offs when used with Deaf people who sign and
to examine the operating characteristics for PHQ-9 BSL and GAD-7 BSL with a clinical Deaf population.
Methods: Two datasets were compared: (i) dataset (n = 502) from a specialist IAPT service for Deaf people; and
(ii) dataset (n = 85) from our existing study of Deaf people who self-reported having no mental health difficulties.
Parameter estimates, with the precision of AUC value, sensitivity, specificity, positive predicted value (ppv) and negative
predicted value (npv), were carried out to provide the details of the clinical cut-offs. Three statistical choices were
included: Maximising (Youden: maximising sensitivity + specificity), Equalising (Sensitivity = Specificity) and Prioritising
treatment (False Negative twice as bad as False Positive). Standard measures (as defined by IAPT) were applied to
examine caseness, recovery, reliable change and reliable recovery for the first dataset.
Results: The clinical cut-offs for PHQ-9 BSL and GAD-7 BSL are 8 and 6 respectively. This compares with the original
English version cut-offs in the hearing population of 10 and 8 respectively. The three different statistical choices for
calculating clinical cut-offs all showed a lower clinical cut-off for the Deaf population with respect to the PHQ-9 BSL
and GAD-7 BSL with the exception of the Maximising criteria when used with the PHQ-9 BSL. Applying the new clinical
cut-offs, the percentage of Deaf BSL IAPT service users showing reliable recovery is 54.0 % compared to 63.7 % using
the cut-off scores used for English speaking hearing people. These compare favourably with national IAPT data for the
general population.
Conclusions: The correct clinical cut-offs for the PHQ-9 BSL and GAD-7 BSL enable meaningful measures of clinical
effectiveness and facilitate appropriate access to treatment when required.
Keywords: British Sign Language, Improving Access to Psychological Therapies, IAPT, BSL, PHQ-9, GAD-7
Background
The PHQ-9 [1] and the GAD- 7 [2] are two of the standard
instruments mandated for use within the IAPT (Improving
Access to Psychological Therapies) national (England) NHS
(National Health Service) programme. IAPT is a large-scale
initiative within the NHS (National Health Service) in
England aimed at redressing long-standing imbalances
between psychological therapy demand and supply. IAPT
services deliver approved psychological interventions to
address common mental health problems in primary
care settings. The PHQ-9 [1] and the GAD- 7 [2] are
used as screening and assessment tools, initially to indicate
caseness (clinical threshold) as one indicator of eligibility
for service. They are subsequently used at each session to
assess progress leading to measurement of recovery and
discharge ([3] p15). Patient and service data are also col-
lected and analysed on a national basis ([3] p16).
Since December 2011, an adapted version of IAPT has
been available, in a small number of geographical areas,
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to Deaf people who are users of British Sign Language
(BSL) [4], henceforth BSL-IAPT. BSL is not a visual,
transliterated version of spoken English [5]. It is an inde-
pendent, fully grammatical visual-spatial language whose
indigenous minority status was formally recognised by
the UK government in 2003 [6] and its legal position
strengthened in Scotland in 2015 [7]. Deaf people’s cul-
tural/linguistic status is conventionally marked by the
use of upper case ‘D’ (Deaf ), rather than by lower case
‘d’ (deaf ) which instead indicates being deaf without BSL
use or its associated cultural identity [8]. IAPT for Deaf
BSL users is particularly important because Deaf people
are more than twice as likely to experience mental
health problems than hearing people [9]. Deaf people’s
access to health services is also much poorer than hear-
ing people’s because of limited availability of information
and treatment delivery in BSL [10, 11] and difficulties at
point of access to services. Failure of services to address
linguistic and cultural needs of Deaf people has been
widely reported in the UK and in other countries [12].
BSL-IAPT uses the standard IAPT instruments, in-
cluding PHQ-9 and GAD-7, but in their validated BSL
translated form. These translations were carried out by
authors 3, 4, 5 following strict protocols agreed with the
originators of the instruments, and construct validity, in-
ternal reliability and test-retest reliability were found
acceptable [13].1 The BSL versions of the standard instru-
ments are delivered on screen, as video-recordings, because
BSL is not a language with a written form. Although PHQ-
9 BSL and GAD-7 BSL are now in current use, the BSL-
IAPT service have used them in conjunction with the
clinical cut-off scores adopted by IAPT ([3] p22): these
scores were derived from studies that have only involved
hearing populations using the English versions.
However, as is the case with any translated version of
a standard instrument, the clinical cut-off that is in use
for one cultural-linguistic population may not be ap-
propriate for another; it cannot be assumed to have the
same sensitivity and specificity as that for the popula-
tion on which it was originally validated [14]. Field test-
ing in the linguistic and cultural population in which
the translated version is applied is required not only to
measure operating characteristics of reliability and val-
idity [15–17], but also to establish whether the clinical
cut-off is the same or different. Such testing has been
carried out for many translations of GAD-7 and PHQ-9
into languages other than English [18] and also with re-
spect to English versions used with populations where
there are cultural differences or particular distinguish-
ing characteristics e.g. a group in another English-
speaking country, one with a specific illness or one
based in primary care [19–22].
The existence of a large dataset of Deaf patients who
were referred to BSL-IAPT between December 2011 and
February 2015 (n = 791), including the use of reliability-
tested, standard BSL versions of the PHQ-9 and GAD-7,
presented a unique opportunity to investigate the clinical
cut-offs of the standard instruments in BSL when used
with a primary care population for purposes of assess-
ment and treatment. This paper reports the operating
characteristics for PHQ-9 BSL and GAD-7 BSL and con-
siders how different approaches to balancing sensitivity
and specificity affect the selection of cut-offs. In this
context sensitivity is the percentage of correctly identi-
fied unhealthy people, and specificity is the percentage
of correctly identified healthy people. The proposed cut-
offs are then retrospectively applied to the data from the
Deaf BSL users seen by BSL-IAPT to consider how they
would have affected eligibility to the service through the
measure of ‘clinical caseness’ ([3] p39) relative to the
English cut-offs. They are also used to calculate ‘recov-
ery’ as defined by the IAPT national programme ([23]
p3), ‘reliable improvement/reliable deterioration’ ([23]
p4) and ‘reliable recovery’ ([23] p5, 25). A summary of
the demographic characteristics of the datasets are re-
ported so comparability between them can be judged.
Methods
Secondary data analysis
This study involves secondary data analysis of the two
datasets: (i) BSL-IAPT clinical dataset; and (ii) dataset of
self-reported well Deaf people derived from a previous
study. The anonymised BSL-IAPT clinical dataset com-
prises all those referred from the inception of the service
(December 2011) to February 2015 (n = 791) and is com-
pared against the study inclusion and exclusion criteria
to identify Dataset 1 (n = 502). As an IAPT service
provider, BSL-IAPT is permitted to hold records of its
clients’ characteristics, adherence and outcomes in ac-
cordance with the IAPT recommended data fields and
client data security arrangements. Dataset 2 is a com-
parator group (n = 85) of Deaf people from our previous
study of the validity and reliability of the PHQ-9 BSL
and GAD-7 BSL [13]. These data were collected in
2011/2012 in a form that does not permit individual
identification of participants, therefore available data on
participant characteristics is restricted to those collected
at the time and retrospective collection of further par-
ticipant characteristics was not possible. The comparator
group self-reported having no mental health difficulties
in the 12 months prior to the study and none were a
current patient under mental health services.
In calculating clinical cut-offs, some studies have eval-
uated PHQ-9 and GAD-7 against an alternative method
of assessment for the same cohort e.g. a clinical inter-
view such as SCID [24]. This was not an option because
of the anonymous status of data to which we had access
and the limits of our ethical approval. Therefore, our
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design compared the two datasets of self-defined ‘well’
Deaf people with ‘not well’ Deaf people, the latter de-
fined as such by virtue of having been assessed by a
MHP (Mental Health Practitioner) as eligible for therapy
through IAPT. The analysis sought to define how well
the two tests discriminated between the two groups
(Dataset 1 and Dataset 2).
Materials
The nine questions of the PHQ-9 score the nine DSM-
IV criteria for depression by a frequency scale from 0 to
3 and the instrument is most commonly scored by the
simple summing of the questions to give an overall total
of 0 to 27. The originators of the instrument established
a score of 10 as the clinical cut-off for moderate depres-
sion in the English version [1], measured against the
‘gold standard’ of an MHP interview. This score yielded
a sensitivity of 88 %, a specificity of 88 % and a positive
likelihood ratio of 7.1. GAD-7 is scored by a frequency
scale from 0 to 3 for each item and is also most com-
monly totalled to give a score between 0 and 21. It was
validated against other health measures and against an
MHP interview. A clinical cut-off of 10 was identified
against the MHP interview diagnosing generalised anx-
iety disorder (GAD) with a sensitivity of 89 % and a spe-
cificity of 82 % [2]. However, a later study [25] evaluated
GAD-7 as a broader instrument to test for any anxiety
disorder and determined an acceptable AUC of 0.86.
From this AUC, a lower cut-off of 8 for any anxiety dis-
order was recommended, which gave a sensitivity of
77 %, a specificity of 82 % and a positive likelihood ratio
of 4.4. This lower cut-off was the one adopted by IAPT
to sit alongside that for the PHQ-9 ([3] p22).
We note that there are, to date, no published analyses
of the operation of the clinical cut-off scores for both in-
struments with respect to the IAPT population in gen-
eral. Patient characteristics in this population, in
comparison with those on which the original cut-off
scores for the English versions were originally derived,
may indicate that a revision of the cut-off scores cur-
rently in use in IAPT services is required. However for
the purposes of this study, we use the published IAPT-
recommended cut-off scores.
Ethics
Ethical permission was sought, and approved by, the
Proportionate Review Sub-committee of NRES (National
Research Ethics Service) Ref: 14/LO/2234 for transfer of
the anonymised Dataset 1 to the research team at the
University of Manchester for the purpose of secondary
data analysis. The people whose data was held within
Dataset 2 had given online consent specifically for sec-
ondary data analysis within other studies, in addition to
consent for the study during which it was first collected.
Ethical permission had been sought and approved at the
time of its collection through NRES Ref: 11/YH/0180.
Participants
Figure 1 shows how the 791 people referred to BSL-
IAPT were checked against the study inclusion and ex-
clusion criteria to identify Dataset 1 (n = 502) and,
within that, the cohorts used for each calculation. The
inclusion criteria were that an individual was a Deaf sign
language user, aged 16 years or over, had accessed BSL-
IAPT services since December 2011, had received a step
2 or 3 service2 [26] and had attended a minimum of one
therapist contact session. The 791 individuals referred to
BSL-IAPT included 40 people who were not BSL users
and were primarily spoken language users, two young
people who were 14 and 15 years old, but had been
assessed as being suitable to be seen by the adult service,
those people who had been clinically judged not suitable
for therapy through IAPT and those people who had had
no appointment. These people were excluded. Of the
Fig. 1 Consolidated Standards of Reporting Trials (CONSORT)-type
diagram for the identification of Dataset 1
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latter group, the most common reason for no appoint-
ment was because the IFR (individual funding request)
submitted for the person to attend a specialist service
had been declined by the CCG (clinical commissioning
group) or a decision was still pending. This reason is
only applicable to referrals since Autumn 2014 as before
this time, commissioning arrangements were different
and the service had been commissioned as a whole
rather than funding being sought for each individual
referral [4].
Analysis
The data were managed and analysed using IBM SPSS
Statistics Version 22. The PHQ-9 and GAD-7 total
scores were calculated using the guidelines in the IAPT
Handbook ([3] p29), which allows the test still to be
considered valid with up to two missing values. In such
instances, one or two missing values can be replaced by
a pro-rata value calculated by taking the mean of the 7
or 8 existing values. The total score is then calculated by
9 [mean value]. Preparatory sample size calculations
were carried out based on Gilbody et al. [22], a study
which observed a sensitivity of 91.7 % and specificity of
78.3 % for PHQ-9 as a screening tool for depression in
93 patients. We assumed a prevalence rate of 33 % for
anxiety and/or depression in the Deaf population based
on the well-cited Kvam et al. study [9] rather than more
general estimates of mental health difficulties in the Deaf
population. Following the same specificity and sensitivity
as in the Gilbody et al. study [22], we estimated that a
90 % CI for an AUC to within +/−0.1 would require a
sample size of at least 117 (39 depressed and 78 not-
depressed patients). This calculation suggested that the
numbers in the respective datasets would be sufficient.
Where new cut-offs have been determined for different
populations, it is uncommon for authors to state clearly
the statistical decisions based on clinical context that in-
fluenced the choice of cut-off. This includes studies
where new cut-offs have been determined within differ-
ent linguistic/cultural populations following translation.
The original papers determining PHQ-9 [1] and GAD-
7 [2, 25] cut-offs did not specify exactly how they made
a statistical choice between, for example, Maximising
(Youden index) [27] or by Equalising sensitivity and spe-
cificity when they were choosing their cut-off. Kroenke
et al. however do state that ‘at a GAD-7 cut-point of 8
or greater, sensitivity and specificity approached or
exceeded 0.75 for all disorders and the positive likeli-
hood ratio exceeded 3.0. The likelihood ratio is similar
to that of most measures used to screen for depression
in primary care.’ ([25] p321). It seems likely that, in their
later review [28], they also used a cost function equalis-
ing sensitivity and specificity, though they do not state
this explicitly.
For both PHQ-9 BSL and GAD-7 BSL, an AUC value
with 95 % CI based on distributional theory was calcu-
lated. Different misclassification cost functions (e.g.
Maximising, Equalising sensitivity and specificity) were
then used to calculate cut-offs and measure sensitivity,
specificity, error rate and positive likelihood ratio. Con-
sidering the discussions about cost function by Kroenke
et al. [28] and Löwe et al. [29], we also calculated a cut-
off which considered false negatives to be twice as bad
as false positives (FN:FP = ~1:2).
Bootstrapping of the sample was used to estimate vari-
ability (i.e. 95 % CI) for cut-off values. Although the re-
sults for the different decisions are presented to show
the variation in psychometric properties when different
cut-offs are used, the cut-off proposed for future use is
that which matches the conditions used by the origina-
tors of the tool i.e. Sensitivity = Specificity [28]. The
bootstrapped 95 % CI for the new BSL cut-off was com-
pared with the English cut-off for each test and a p value
was calculated to see if there was a statistically signifi-
cant difference between the clinical cut-off values.
The standard measures defined by IAPT were used in the
analysis. ‘Caseness’ ([3] p39) pertains to entry into the ser-
vice: an individual is defined as having reached caseness if
they have a score equal to or higher than the cut-off on
PHQ-9 and/or GAD-7 at assessment. The second IAPT-
specific measure is ‘recovery’ ([23] p3): this is said to have
been reached when a client’s PHQ-9 and GAD-7 scores
both fall below the clinical cut-off and they were at ‘case-
ness’ at intake. Gyani et al. [30], in their detailed analysis of
client data from the first year of IAPT operation,
highlighted that ‘this measure does not take into account
whether the observed change is greater than the measure-
ment error of the scales’ ([30] p599). Additionally, a small
improvement taking an individual from just above to just
below the clinical cut-off is classified as recovery, whereas
an individual who started with a high score on one or both
instruments and has greatly improved, but did not fall
below cut-off, is not counted. The additional use of a for-
mula to calculate a reliable change index (RCI) [31], equiva-
lent to a score change of at least twice the standard error,
was therefore proposed by Gyani et al. [ibid]. The RCI en-
ables the quantification of ‘reliable improvement’ and ‘reli-
able deterioration’ i.e. a score change larger than the RCI
signals a clinically significant change. This measure, when
combined with ‘recovery’, enables the identification of those
individuals who have ‘reliably recovered’ i.e. shown both ‘re-
covery’ and ‘reliable improvement’. IAPT have recently
moved to adopt the use of ‘reliable recovery’ alongside ‘re-
covery’ [23, 32]. Following this lead, the reliable change in-
dices (RCI) for PHQ-9 BSL and GAD-7 BSL were
calculated using Jacobson and Truax’s criteria formula [31].
The measure of reliability used in the calculation was the
measure of internal reliability, Cronbach’s alpha: a choice
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supported by Evans et al. [33] and previously calculated by
authors 3, 4, 5 [13].
The newly identified cut-offs and reliable change indi-
ces for PHQ-9 BSL and GAD-7 BSL were then retro-
spectively applied to Dataset 1 to calculate how many of
the clients reached caseness, recovery and reliable recov-
ery and how many showed reliable improvement or reli-
able deterioration. Reliable improvement is defined as a
fall in score for one instrument greater than the RCI,
whilst the score for the other instrument either also reli-
ably improves or does not show reliable change. Reliable
deterioration is the opposite; a rise in score for one in-
strument whilst the other instrument also shows reliable
deterioration or no reliable change. Any other combin-
ation of score changes (e.g. one instrument shows reli-
able change, but the other shows reliable deterioration,
or both show no reliable change) is labelled as no reli-
able change. Additional analysis of Dataset 1 allowed
characterisation of the cohort in terms of demographics
and origin of referral.
Results
Population characteristics
Datasets 1 and 2 were compared in respect of the available
demographic descriptors to judge whether the groups were
comparable (Table 1). Gender, age and ethnicity were avail-
able for both datasets and showed a similar male/female
split, mean age (Dataset 2 was slightly skewed towards
younger age brackets) and the proportion of respondents/
clients who indicated that they were of White-British ethni-
city. The question on disability to the participants in Data-
set 2 did not exclude being deaf. Dataset 2 contained a
higher proportion with a declared disability compared to
Dataset 1. In the latter groups, type of disability was broken
down so being deaf could be excluded and it was variable
whether individuals indicated being deaf as a disability: this
is likely to be the same for Dataset 2, although this cannot
be confirmed from the available data.
Establishing clinical cut-offs and reliable change indices
Table 2 shows the numbers within each dataset that
were valid for calculating the cut-offs.
Figure 2 shows the distribution of PHQ-9 BSL scores for
the two datasets and the ROC analysis. The AUC for PHQ-
9 BSL was 0.94 with a 95 % CI of 0.91–0.96. Figure 3 shows
the equivalent figures for GAD-7 BSL. The GAD-7 BSL
tool had an AUC of 0.96 with a 95 % CI of 0.94–0.98. Both
tools therefore show excellent discrimination.
Table 3 shows that, for the BSL versions, the sensitivity
& specificity are high for the cut-offs corresponding to
both the Maximising and Equalising functions. The
overall error rates of both are fairly low, but when a cut-
off that equalises sensitivity and specificity is used for
PHQ-9 BSL, the higher sensitivity and lower specificity
is a better balance between type I and type II errors, giv-
ing a lower overall error rate. The LR + =sens/(1-spec)
criteria (i.e. that LR+ > 3) used by Kroenke et al. [25] in
deciding the cut-off for GAD-7 was also passed by the
BSL cut-offs. Kroenke et al. [ibid] also required that both
sensitivity & specificity > =0.75, which the BSL cut-offs
satisfy. The exception to this, of course, is the cut-offs
for FN:FP = ~1:2, where the sensitivity is taken to be far
more important than the specificity.
It was decided to match the choice made by the origi-
nators of the English instruments and recommend the
Table 1 Description of Datasets 1 and 2 with respect to
demographic characteristics
Demographic Dataset 1 (n = 502) Dataset 2 (n = 85)
Number/Valid
number
% Number/Valid
number
%
Female gender 303/502 60.4 49/84 57.6
Age range 16–80/502 22–68/83
Mean age 42 (13.2 SD) 40
Ethnicity White-British 358/425 84.2 74/83 89.2
Religious belief Christian 140/215 65.1
Sexual orientation
Heterosexual
266/322 82.6
Relationship: married/
partner
151/376 40.2
Relationship: single 153/376 40.7
Relationship: divorced/
widowed
72/376 19.1
National Identity English 143/149 96.0
Declared disability 45/502 9.0a 28/83 33.7b
Has long-term health
condition
83/374 22.2
Prescribed psychotropic
medication
175/435 40.2
Receiving sick pay 16/434 3.7
In paid employment 110/433 25.4
Previously accessed
Standard IAPT
219/502 43.6
Provisional diagnosis
depression
120/414 29.0
Provisional diagnosis
anxiety
49/414 11.8
Provisional diagnosis
mixed anxiety and
depression
208/414 50.2
Provisional diagnosis
other
37/414 8.9
North West Region 323/502 64.3
Primary care referral 192/502 38.2
Self-referral 205/502 40.8
Other referral source 105/502 20.9
aQuestion excluded being deaf, bQuestion did not exclude being deaf
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cut-offs corresponding to sensitivity = specificity, thus
allowing easier comparisons between users of the dif-
ferent language versions. This gives a PHQ-9 BSL clin-
ical cut-off of 8 (in comparison to 10 for the original
English version) and, for the GAD-7 BSL, a clinical cut-
off of 6 (in comparison to 8 for the original English ver-
sion). T-tests examined whether the English PHQ-9
and GAD-7 cut-offs (Equalising) are the same as PHQ-
9 BSL and GAD-7 BSL (Equalising), based on 1000
bootstrap replicates to gain a 95 % CI for the cut-offs.
These tests gave strong evidence (p = 0.0003, p = 0.0002
respectively) against the hypothesis that they are equal
[34]. The conclusion was that the new cut-offs for
PHQ-9 BSL and GAD-7 BSL are significantly different
from the English cut-offs.
Table 4 shows the reliable change indices (RCI) calcu-
lated for PHQ-9 BSL and GAD-7 BSL. BSL values for
the reliable change index were shown to be slightly
higher than the values for the English version used with
the hearing population.
Caseness, recovery, reliable change and reliable recovery
Of the 502 patients in Dataset 1, 429 have a first PHQ-9
BSL score and/or a first GAD-7 BSL score. This would
have been used by the service for establishing caseness
(see Fig. 1). Table 5 illustrates the application of the
English cut-off scores to this cohort of 429, in compari-
son with the application of the BSL cut-off scores,
dependent on which statistical decision is applied.
The lower cut-offs for the BSL instruments mean that
a larger proportion of those referred would have reached
caseness and therefore potential eligibility for therapy
under the service.
‘Recovery’ can be calculated for those clients with at
least two appointments and who were at caseness at the
start of therapy (n = 349) (Table 6).
The lower cut-offs for the BSL instruments mean that
the apparent recovery rate drops compared to when the
English cut-off is applied to Dataset 1. However, recovery
rates for the BSL-IAPT service are still comparable to the
range for IAPT services nationally [30, 35], even when the
lower BSL cut-offs are used. The cohort used in Table 6 in-
cludes clients who, for example, dropped out before the
end of therapy, who were referred on to other services part-
way through therapy or those who were still in therapy at
the time of data collection. If the cohort is narrowed to only
those who have completed therapy (Table 7), the propor-
tion who reached recovery is much higher than in Table 6.
Table 2 Valid numbers of participants for calculating clinical cut-offs for PHQ-9 BSL and GAD-7 BSL
Dataset 1 (Data from BSL-IAPT Deaf
clients 2011–2015) n = 502
Dataset 2 (Data from self-reported healthy Deaf
participants from Rogers et al. [13]) n = 85
Valid number of participants Mean instrument score Valid number of participants Mean instrument score
PHQ-9 BSL Score 433 14.58 (SD = 5.99) 85 3.62 (SD = 3.29)
GAD-7 BSL Score 432 12.50 (SD = 4.98) 84 2.13 (SD = 2.48)
Fig. 2 Distribution of PHQ-9 BSL scores for the two groups; ROC curve for PHQ-9 BSL
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‘Reliable recovery’, combining ‘reliable change’ with ‘re-
covery’, was calculated for the 226 clients from Dataset 1
who had at least two appointments, who had reached
caseness at the start of therapy and who had completed
therapy (Table 8).
78.3 % of clients showed reliable improvement using
the English reliable change index, compared to 76.5 %
using the BSL reliable change index. This drop is due to
the RCI being slightly higher for the BSL instruments: a
function of the lower internal reliability as measured by
Cronbach’s alpha. The need for a bigger change on the
BSL instruments in order to register as a clinically
significant change also affects the number who showed
reliable deterioration: 3.5 % using the English RCI com-
pared to 2.7 % using the BSL RCI.
As would be expected, the measure of ‘reliable recov-
ery’ shows the same trend as the measure of ‘recovery’:
that the lower cut-offs for the BSL instruments indicate
that a lower percentage of clients have recovered under
this measure.
Discussion
Operating characteristics of PHQ-9 BSL and GAD-7 BSL
There were a number of factors, statistical and practical,
to consider in deciding which cut-offs to recommend.
The existing literature was carefully reviewed with the
aim of matching, where possible, the same statistical pri-
orities chosen by the originators of the instruments,
which would lead to the choice of cut-offs which equal-
ise specificity and sensitivity. In addition, the comparison
of the error rates between the Maximising and Equalis-
ing criteria with our data (Table 3) showed a lower over-
all error rate when using the latter cut-offs. The cut-offs
that will therefore be proposed to IAPT for future use
(alongside the BSL instruments) are a score > =8 for
PHQ-9 BSL as equivalent to a clinically significant level
of depression and a score > =6 for GAD-7 BSL as
Fig. 3 Distribution of GAD-7 BSL scores for the two groups; ROC curve for GAD-7 BSL
Table 3 PHQ-9 and GAD-7 cut-offs compared with PHQ-9 BSL
and GAD-7 BSL cut-offs, indicating different statistical choices
English version (Cut-offs calculated on hearing population)
Cut-off choice [95 % bootstrap CI] PHQ-9 GAD-7
Equalising sens = spec 10 8
sens, spec 88 %, 88 % [28] 77 %, 82 % [28]
BSL version (Cut-offs calculated on Deaf population)
Cut-off choice PHQ-9 BSL GAD-7 BSL
Maximising Maximise sens + spec 10 [8.1, 13.2] 6 [5.1, 7.2]
sens, spec 78 %, 95 % 91 %, 94 %
Error 19.3 % 8.3 %
LR+ 16.5 15.3
Equalising sens = spec 8 [6.5, 8.7] 6 [5.1, 7.2]
sens, spec 86 %, 81 % 91 %, 94 %
Error 14.5 % 8.3 %
LR+ 4.6 15.3
Prioritising
treatment
FN:FP = ~1:2
Cost function: false
negative judged
twice as bad as false
positive
4 [2.1, 7.2] 3 [0.0, 3.9]
sens, spec 96 %, 55 % 97 %, 67 %
Error 10.8 % 7.8 %
LR+ 2.1 2.9
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equivalent to a clinically significant level of an anxiety
disorder.
The majority of studies which determine the cut-off
score for an assessment have a larger healthy population
dataset than the clinical population dataset [36]. With
this study, however, we have a larger dataset from the
Deaf clinical population than the sample of well Deaf
people. As a consequence, we know more precisely the
empirical distribution of the clinical Deaf population
and therefore have more precise estimates of sensitivity
than of specificity.
The reasons for the different cut-off scores in the Deaf
population are unknown. We suggest that further re-
search is needed to explore the potential reasons, but
there are a number of hypotheses. It could be that the
composition of the cohorts, in terms of their mental
health, is different from the cohorts tested by the origi-
nators of the tools when calculating the original English
cut-offs. There is much research recognising the poten-
tial impact of characteristics of the studied sample on
the psychometric properties of the instruments e.g. a
population with concurrent health problems or a popu-
lation based within primary versus secondary care [28].
In contrast, it has not often been acknowledged in the
literature that the actual construct being examined i.e.
depression or anxiety, may vary within a particular lan-
guage and/or cultural community. For example, during
reliability testing of PHQ-9 BSL [13], two components
rather than one were extracted. Previous studies in hear-
ing populations had found, almost universally, one com-
ponent for PHQ-9. Two possible reasons were put
forward in discussion: that depression is culturally deter-
mined differently amongst the Deaf population and/or
that certain parts of the instrument measured facets that
may be answered differently by Deaf people for other
reasons e.g. experiencing a lack of motivation to socialise
and meet people may be not as a result of feeling de-
pressed, but rather be a response to many Deaf people’s
normal experiences of social contexts where most of the
hearing people within them are unable to communicate
in BSL ([13] p117). This hypothesis is lent support in a
validation study of the BSL version of EQ-5D-5 L (health
questionnaire) [37], where a small number of Deaf
people were interviewed to find out how they under-
stood key terms contained within EQ-5D-5 L BSL. This
revealed that everyday experiences of communication
barriers could affect the conceptualisation of key terms
e.g. when asked about ‘mobility’ difficulties, a reply could
be influenced by considerations of whether an individual
was concerned about how easy or not it would be to
communicate when buying a train ticket [ibid].
Implications of new recommended clinical cut-offs
The provision of the BSL-IAPT specialist service was in
response to the fact that Deaf people experience signifi-
cantly poorer mental health than the hearing population,
with studies suggesting that the prevalence of some com-
mon mental health problems is twice as high [9, 10, 38].
Furthermore, studies have demonstrated the inaccessibility
of health services to Deaf people who use British Sign
Language [10, 38–45]. This includes mental health ser-
vices, and can result in late diagnoses and loss of bene-
fit from early preventative interventions [12]. Deaf
Table 4 Reliable change indices for PHQ-9 and GAD-7 compared with PHQ-9 BSL and GAD-7 BSL
English version
(hearing population)
BSL version
(Deaf population)
PHQ-9 GAD-7 PHQ-9 BSL GAD-7 BSL
Cronbach’s alpha 0.89 ([1] p608) 0.92 ([2] p1094) 0.81 ([13] p115) 0.88 ([13] p116)
Standard deviation of pre-therapy scoresa N/A N/A 5.52 4.49
Standard error of differenceb N/A N/A 3.40 2.20
Reliable change index 5.20 ([30] p599) 3.53 ([30] p599) 6.66b 4.31b
an = 411 from those reaching caseness using the Equalising cut-off – see Table 5
bfollowing Jacobson and Truax [32 p14]
Table 5 Number of clients within Dataset 3 (n = 429) meeting
or not meeting caseness under the cut-off scores
Cut-off used Number of
clients meeting
caseness under
this cut-off
Number of clients
not meeting
caseness under
this cut-off
Percentage of
clients meeting
caseness under
this cut-off
English: Equalising 392 37 91.4
BSL: Maximising 406 23 94.6
BSL: Equalising 411 18 95.8
BSL: Prioritising
(FN:FP = ~1:2)
423 6 98.6
Table 6 Dataset 1 recovery rates after a minimum of two
appointments and starting therapy at caseness (n = 349)
Cut-off used Number of
clients reaching
recovery under
this cut-off
Number of clients
not reaching
recovery under
this cut-off
Percentage of
clients reaching
recovery under
this cut-off
English: Equalising 187 162 53.6
BSL: Maximising 157 192 45.0
BSL: Equalising 150 199 43.0
BSL: Prioritising 70 279 20.1
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people are often users of mental health services only
when a difficulty has escalated to the point where sec-
ondary/tertiary care intervention is required [10, 40,
41]. BSL-IAPT, where available, provides an accessible
primary mental health care intervention. The service is
delivered by qualified Deaf practitioners who use BSL
during therapy. This ensures a linguistically and
culturally-matched mental health intervention without
the requirement of an interpreter. Although the PHQ-9
BSL and GAD-7 BSL have been available for use by
BSL-IAPT since inception, until now they have been
used with the cut-offs that were determined for the ori-
ginal English versions, which had been determined
using a hearing-only cohort. Our results show that the
assumption that the same cut-offs should be applied to
the Deaf population is flawed because it gives a worse
outcome in terms of the clinical impact.
Applying the cut-offs that have been developed for
the hearing population to the two datasets gives a
higher overall error (i.e. a higher combined proportion
of missed unwell individuals and well individuals
wrongly assessed as unwell) compared to the proposed
new cut-offs. Missed unwell individuals can result in
further deterioration of their mental health, which in
turn can be costly for individuals, wider society and the
economy. The findings suggest that the lower cut-offs
can improve the reliability and quality of IAPT services
when delivered to Deaf people using the BSL instru-
ments. This is not only the case for the individual mon-
itoring of someone’s mental health during assessment
and therapy, but creates a platform for future second-
ary data analysis of a large clinical cohort of Deaf
people that will be trustworthy and more meaningful.
Furthermore, the determination of lower clinical cut-
offs means that Deaf BSL users should benefit from ser-
vices at an earlier stage of mental health difficulties.
The current cut-offs used for the hearing population
run the risk of deteriorating mental health problems
and this could prove costly in terms of both the finan-
cial implications and the impact on the individual who
receives less timely interventions.
The IAPT service chose the cut-offs for the English
version because of relatively high sensitivity at these
levels. Papers working with these instruments and de-
termining standard clinical cut-offs have broadly used
a cost function that treats false positives and false neg-
atives as being equally bad. However, Kroenke et al.
([28] p352) highlights that ‘one might choose a differ-
ent cutpoint depending upon the population being
assessed (community vs. primary care vs. mental health
setting) and the purpose of the assessment (routine
screening vs. evaluating suspected cases)’. Considering
the known challenges for the Deaf population who use
BSL to access services, there is a case to be made for
using lower cut-off points. A cost function prioritising
treatment was therefore calculated and could be used
in primary care as a preliminary screening tool to
judge which Deaf BSL users may benefit from an as-
sessment by a specialist (or adapted standard) service
that has the linguistic and cultural resources to carry
out a fuller interview. The instruments are one elem-
ent of the wider assessment.
Table 7 Dataset 1 recovery rates after a minimum of two
appointments, starting at caseness and completed therapy
(n = 226)
Cut-off used Number of
clients reaching
recovery under
this cut-off
Number of clients
not reaching
recovery under
this cut-off
Percentage of
clients reaching
recovery under
this cut-off
English: Equalising 160 66 70.8
BSL: Maximising 137 89 60.6
BSL: Equalising 131 95 58.0
BSL: Prioritising 63 163 27.9
Table 8 Dataset 1 reliable change/reliable recovery rates after a minimum of two appointments, starting at caseness and completed
therapy (n = 226)
Cut-off and RCI used Clients showing
recovery
Clients showing reliable
improvement
Clients not showing
reliable change
Clients showing reliable
deterioration
Clients showing
reliable recovery
English version (English RCI)
Equalising Number 160 177 41 8 144
Percentage 70.8 78.3 18.1 3.5 63.7
BSL version (BSL RCI)
Maximising Number 137 173 47 6 127
Percentage 60.6 76.5 20.8 2.7 56.2
Equalising Number 131 As above As above As above 122
Percentage 58.0 54.0
Prioritising Number 63 As above As above As above 62
Percentage 27.9 27.4
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Proportion reaching caseness, recovery and reliable
recovery
Retrospectively applying the new cut-offs PHQ-9 BSL > =8
and GAD-7 BSL > =6 to the cohort of Deaf BSL users
referred to BSL-IAPT indicated that a greater propor-
tion would have been at caseness and therefore eligible
for therapy. This has implications for resourcing ser-
vices. In addition, a smaller proportion are indicated to
have recovered/reliably recovered using the new cut-
offs, compared to the English cut-offs used in the na-
tional reporting, although it is of note that the levels of
recovery still compare favourably with the national
figures [35]. It was previously reported in the BSL
Healthy Minds’ Evaluation Report, that for the first
20 months of operation [46] the recovery rate using the
old clinical cut-offs was 75 %, compared to 70.8 % cal-
culated in our larger study. However, calculations on
our data using the new clinical cut-offs give 58 %
reaching recovery and 54 % reaching reliable recovery,
as defined by IAPT. These lower rates still reach the
target set by the IAPT programme of at least 50 %
reaching recovery [23]. As well as reflecting the quality
of therapy provided by the service, there are likely to be
other factors influencing recovery for this cohort.
With the additional barriers to accessing services, it
can be hypothesised that clients may take longer to
reach the service and therefore may have poorer mental
health, and correspondingly higher scores on these in-
struments by the time they are seen. If this is the case,
this may impact on the amount of improvement that is
needed for a client’s score to reach the recovery cut-offs
and, consequently, on the recovery rate. However, we
would contend that showing reliable change rates gives a
more balanced picture of progress through therapy. For
example, individuals may take longer to recover if they
have worse mental health to begin with, but may show
faster or larger improvement scores even if recovery is
not reached. Currently, it is not possible to make direct
comparisons for the same timeframe as the nationally
reported IAPT figures are for the predominantly hearing
population and the newer measures of reliable change
and reliable recovery were only adopted by IAPT in
April 2015.
Limitations
A limitation of our methodology was not having the re-
sources to use a clinical interview. This would have pro-
vided a clinical ‘gold standard’ against which to measure
the PHQ-9 BSL and GAD-7 BSL. Instead, in order to
calculate the cut-offs, the methodology used discrimin-
ation between a group defined as having a mental health
problem (Dataset 1) and a group who self-reported as
not having a mental health problem. Whilst we consider
that the choice of methodology was robust, it is different
from that used by the originators of PHQ-9 and GAD-7.
In order to validate further the clinical cut-offs for PHQ-
9 BSL and GAD-7 BSL, the inclusion of a clinical inter-
view would be required.
Dataset 2, the well group comparator, also had some
limitations. The anonymous data were derived from a
pre-existing study and it was not possible to retrospect-
ively gain additional information about patient charac-
teristics that would have enabled stronger judgement of
comparability to be made between the two datasets. The
dataset also relied on a self-definition of well, as judged
by no current mental health difficulties and no use of a
mental health service for the past 12 months. Although
self-reporting could be seen as a limitation in that indi-
viduals may not have been truthful, there was additional
evidence for better mental health of this group in that
the mean scores of the BSL versions of the PHQ-9 and
GAD-7 were significantly lower in comparison to the
other group from the same study who self-reported that
they had experienced mental health difficulties in the
past 12 months [13]. Additionally, the sample in dataset
2 might be perceived as being healthier than the general
population, which could in turn contribute to lower cut
offs. However this is not the case; the mean score for de-
pression, as measured by PHQ-9, for the sample of
‘healthy’ Deaf people from our previous study (REF:
[13]) (mean score of 3.62) is higher than the commonly
reported mean score of the control group in some stud-
ies of hearing populations (e.g. a mean score of 2.31 in
the study of Reiner et al. [47]; and a mean score of 2.55
in the study of Hanwella, Ekanayake and de Silva [48].
Therefore healthy Deaf people in dataset 2 are not
healthier than the general hearing population and this is
unlikely to be the reason for lower clinical cut-offs.
We acknowledge there is a source of potential error in
calculating caseness and reliable recovery for the Dataset
1 participants using the usual IAPT clinical cut-offs in
comparison with the newly calculated BSL clinical cut-
offs. To our knowledge, there are no published studies
that have examined the operational characteristics of the
clinical cut-offs for the GAD7 and PHQ 9 specifically
with the general population of IAPT users and therefore
some uncertainty remains as to whether the cut-offs de-
rived from the original validation studies for the two in-
struments are appropriate for use within the IAPT
service. Indeed, there continues to be recognition that,
as discussed in the background section, clinical cha-
racteristics and statistical decisions both influence the
selection of most appropriate cut-off [14]. We also ac-
knowledge that there is greater uncertainty associated
with the use of the clinical cut-offs for the two instru-
ments as a screen for caseness in comparison with their
use for diagnostic purposes [49–51]. It will be interesting
in future studies to examine this issue also with respect
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to the Deaf population and the cut-offs now established
for the instruments in BSL.
Conclusions
The primary aim of this research was to explore the op-
erating characteristics of the PHQ-9 BSL and GAD-7
BSL instruments within IAPT in order to improve reli-
ability and quality when delivering therapies to Deaf
people and using the BSL instruments. Appropriate clin-
ical cut-offs for these instruments are now established
for Deaf BSL users. Assessment of the clinical effective-
ness of BSL-IAPT, both for clinical practice and to allow
accurate comparison with mainstream IAPT services,
can now be made. Comparison is important in the na-
tional (English) monitoring of IAPT services through the
mandatory data that flows upwards to the HSCIC
(Health and Social Care Information Centre) [35].
Endnotes
1A third instrument, WSAS (the Work and Social
Adjustment Scale) [52] was also translated alongside the
PHQ-9 and GAD-7 [13] and is in use by BSL-IAPT. It is
not addressed in this paper because the originators did
not intend it to be used with a clinical cut-off as a
standalone diagnostic and recovery tool. Rather, it is
intended as ‘a self-report scale of functional impairment
attributable to an identified problem’ [52].
2Step 2 and Step 3 are part of the stepped care
programme set out in the NICE guidelines and imple-
mented within the IAPT programme [26]. Step 2 en-
compasses low-intensity interventions such as guided
self-help and encouragement from a psychological well-
being practitioner (PWP) and Step 3 is defined as high-
intensity interventions such as weekly, one-to-one
therapy sessions.
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